Suit Says Cytodyne Omitted Side Effects From Ephedra-Free Supplement Label
This article was originally published in The Tan Sheet
Executive Summary
The New Jersey Attorney General's Office and the state's Division of Consumer Affairs are seeking to enjoin Cytodyne Technologies from making or disseminating further advertisements that contain unsubstantiated claims about its Xenadrine EFX ephedra-free dietary supplement
You may also be interested in...
Xenadrine Safety Misrepresentations Alleged In Bechler Suit v. Cytodyne
Cytodyne's failure to adequately warn consumers about potential risks from taking ephedra-containing Xenadrine RFA-1 is the basis for a wrongful-death lawsuit filed by Orioles pitcher Steve Bechler's widow, Kiley Bechler, July 16
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands